APHY: Incredible Growth Indicates Good Business Plan and Ability to Execute
Assured Pharmacy – APHY – Stock Guru Profile
Robert DelVecchio, CEO of Assured Pharmacy told Stock Guru today: “We believe we will have a national footprint in five to seven years”
That will be easier than it sounds. Assured Pharmacy has developed a business model with an history of success and is on track to be EPS positive by Third Quarter 2007!
They have proven their concept is more than viable, that it fills a void while simultaneously proving they have what it takes to run their unique pharmacy for chronic pain sufferers!
Assured Pharmacy works directly with the physician to create the specialized and often unique compounded prescription for the individual patient’s chronic pain. Providing adequate analgesia for patients with moderate to severe pain may require the use of multiple medications, often at high dosages. Assured Pharmacy makes available to physicians and patients a mixture of standard and customized pharmacy products and services.
There is a tremendous need for specialized phamacies. Many, many pharmacies have elected NOT to dispense narcotics. Chronic pain patients are often viewed as addicts by pharmacies.
By stocking narcotic medicatiaons and being able to create specialized compounds pursuant to the physcians customized directive for the patient’s specific needs Assured Pharmacy has enjoyed a dramatic increase in revenue. Robert DelVecchio became CEO in February of 2005 and the pharmacies have experienced tremendous growth which was unimpeded by WalMart’s entrance into low cost prescriptions!
2005
Sales increase to $3.8MM from $900K in 2004
2006
Established corporate infrastructure to support 20 stores
Opened first new pharmacy since 2004
Sales increase to $7.9MM from $3.8MM in 2005
2007
Opened second new pharmacy since 2004
Cash flow positive by Q207 / EPS Profitable by Q307
Intend to open at least 5 new pharmacies
Sales projected to be $16MM to $18MM based solely on same store sales
The story for 2007 is a proof positive growth story:
2007 should see Assured Pharmacy reach their same store sales target of $16MM to $18MM with the openin of five new pharmacies. Their salesforce increase is in the process of increasing from two to eight. Robert DelVechio’s business model is producing gross margins approaching 30% with an underlying infrastructure in place to support 20 stores.
Assured Pharmacy is on track to be earnings per share profitable by the Third Quarter of 2007 … and that’s proof positive this business model functions at an incredibly high level!
This company DOES NOT compete with Wal-Mart! This company fills a void in patient and physician pharmacy needs! Their success is reflected in expanding sales!
Stay tuned to understand why specialized pharmacies appeal to physicians who treat patients with chronic pain.
Source: APHY
Robert DelVecchio, CEO
Assured Pharmacy, Inc.
17935 Sky Park Circle, Ste. F Irvine, CA 92614
Phone: (949) 222-9971
Fax: (949) 222-0978
Website: www.assuredpharmacy.com
About Assured Pharmacy: Assured Pharmacy provides customized services for patients with and physicians treating chronic pain, including specialized expertise in dispensing pain medication, including Class II substances, streamlined prescription processes, digital prescribing technologies, and specialty drug compounding services. APHY also offers a complete line of durable medical equipment through its DME division. APHY currently operates retail sites in Portland, Oregon (three), Santa Ana and Riverside, California, and Kirkland, Washington. More information about APHY is available at http://www.assuredpharmacy.com.
Forward Looking Statements: Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC has been compensated $10,000 directly from the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.